If you would like to discuss anything press related, please email

RareCan in the news

Atelerix and RareCan press release –

Sarcoma UK announces partnership with RareCan – 25th July 2023 –

Neuroendocrine Cancer UK announces partnership with RareCan – 10th July 2023 –

NS Healthcare –

PharmaTimes – 23rd June 2023 –

Blood Cancer UK – 23rd June 2023 –

Business Live – 1st March 2023 – RareCan eyes up to 3m investment this year

Barclays Eagle Labs – 22nd July 2022 – How our health tech startup secured public sector partnerships

UK Business Angels Association – 5 July 2022 – Newcastle – based Rare Cancer Research Start-Up RareCan Secures Six Figure Investment to Grow Business

Britain Daily – 30 June 2022 – House Music Pioneer and Star DJ Sasha to Play Intimate Gig to Help Dad Speed Up Research into Rare Cancers

Newcastle University – 28 June 2022 – Retired Professor sets up Business to Accelerate Rare Cancer Research

Innovation Super Network North East England – 27 June 2022 – Newcastle Based Rare Cancer Research Start Up Secures Six Figure Investment to Grow Business

Inside Media – 24 June 2022 – Medical Research Platform Smashes Crowdfunding Target

Business Live – 20 June 2022 – Female angel syndicate helps Northern founders raise almost £2.5m in first year

National Health Executive – 24 January 2022 – Digitalisation of Clinical Trials

Novopath – 9 December 2021 – Novopath & RareCan Research and Innovation Collaboration 

Newcastle Chronicle – 25 November –  Inside the Newcastle ‘BioBank’ of blood and tissue samples which could help cure rare cancers

Drug Discovery World – 23 November – Accelerating Research:  The Path Forward for Treating Rare Cancers

Adlib Recruitment – 19th November –  Product People Potential – Our Chat with RareCan Limited

weareumi – 10th November – Go Further Investment Index Celebrates most Progressive Northern UK Businesses 

EPM Magazine – 9th November – Blood Cancer UK Partners with RareCan to Improve Delivery of Clinical Trials

Technology Networks – 9th November – RareCan Receives Approval from NHS Research Ethics Committee to Establish Vital BioResource at Newcastle University

Northern Echo – 4th November – Teesside University New Cancer Treatment Research Partnership

PharmaTimes – 2nd November 2021  – Putting Digitally Empowered Patients at the Core of Rare Cancer Research

Drug Discovery World – 26th October 2021 – RareCan Receives approval to establish BioResource at Newcastle University

Newcastle Chronicle – 5th October 2021 – Newcastle professor’s ‘matchmaking’ site helps patients with rare cancers find the clinical trials that could save their lives 

Pharmafile – 25th August 2021  – RareCan appoints Dr Anita Cooper

Drug Discovery World – 4th August 2021 – Appointment strenghtens the experience of RareCanGMe